Unknown

Dataset Information

0

A potent truncated form of human soluble CR1 is protective in a mouse model of renal ischemia–reperfusion injury


ABSTRACT: The complement system is a potent mediator of ischemia–reperfusion injury (IRI), which detrimentally affects the function and survival of transplanted kidneys. Human complement receptor 1 (HuCR1) is an integral membrane protein that inhibits complement activation by blocking the convertases that activate C3 and C5. We have previously reported that CSL040, a truncated form of recombinant soluble HuCR1 (sHuCR1), has enhanced complement inhibitory activity and improved pharmacokinetic properties compared to the parent molecule. Here, we compared the capacity of CSL040 and full-length sHuCR1 to suppress complement-mediated organ damage in a mouse model of warm renal IRI. Mice were treated with two doses of CSL040 or sHuCR1, given 1 h prior to 22 min unilateral renal ischemia and again 3 h later. 24 h after reperfusion, mice treated with CSL040 were protected against warm renal IRI in a dose-dependent manner, with the highest dose of 60 mg/kg significantly reducing renal dysfunction, tubular injury, complement activation, endothelial damage, and leukocyte infiltration. In contrast, treatment with sHuCR1 at a molar equivalent dose to 60 mg/kg CSL040 did not confer significant protection. Our results identify CSL040 as a promising therapeutic candidate to attenuate renal IRI and demonstrate its superior efficacy over full-length sHuCR1 in vivo.

SUBMITTER: Bongoni A 

PROVIDER: S-EPMC8575974 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC4699807 | biostudies-literature
| S-EPMC3888358 | biostudies-literature
| S-EPMC4323259 | biostudies-literature
| S-EPMC5501469 | biostudies-literature
| S-EPMC8185668 | biostudies-literature
| S-EPMC9448582 | biostudies-literature
| S-EPMC2396738 | biostudies-literature
| S-EPMC10141369 | biostudies-literature
| S-EPMC4243358 | biostudies-literature
| S-EPMC3387652 | biostudies-literature